Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Co-Altered Lung Adenocarcinoma

被引：0
|
作者：
Cai, Weijing [1 ]
Zhou, Caicun [1 ]
Lin, Dongmei [2 ]
Wu, Chunyan [3 ]
Li, Xuefei [1 ]
Zhao, Chao [1 ]
Zheng, Limou [4 ]
Fei, Ke [5 ]
Hirsch, Fred R. [6 ,7 ]
机构：
[1] Shanghai Pulm Hosp, Med Oncol, Shanghai, Peoples R China
[2] Beijing Canc Hosp, Beijing, Peoples R China
[3] Shanghai Pulm Hosp, Pathol, Shanghai, Peoples R China
[4] Xiamen Univ, Translat Med Ctr, Xiamen, Peoples R China
[5] Shanghai Pulm Hosp, Thorac Surg, Shanghai, Peoples R China
[6] Univ Colorado, Ctr Canc, Dept Med, Aurora, CO USA
[7] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
ALK rearrangement; ALK/EGFR co-alteration; lung adenocarcinoma; Intratumoral Heterogeneity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI10.02
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor
    Park, Sehhoon
    Han, Joungho
    Sun, Jong-Mu
    [J]. LUNG CANCER, 2019, 127 : 66 - 68
  • [42] Metabolic and metastatic features of ALK-rearranged lung adenocarcinoma: An FDG PET/CT study
    Choi, Hongyoon
    Paeng, Jin Chul
    Kim, Dong-Wan
    Lee, June Koo
    Chung, June-Key
    Lee, Dong Soo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
    Yun, Mi Ran
    Choi, Hun Mi
    Lee, You Won
    Joo, Hyeong Seok
    Park, Chae Won
    Choi, Jae Woo
    Kim, Dong Hwi
    Kang, Han Na
    Pyo, Kyoung-Ho
    Shin, Eun Joo
    Shim, Hyo Sup
    Soo, Ross A.
    Yang, James Chih-Hsin
    Lee, Sung Sook
    Chang, Hyun
    Kim, Min Hwan
    Hong, Min Hee
    Kim, Hye Ryun
    Cho, Byoung Chul
    [J]. EMBO MOLECULAR MEDICINE, 2019, 11 (12)
  • [44] ALK-Rearranged May Promote VTE by Increasing the Expression of TF in Advanced Lung Adenocarcinoma
    Sen, Y.
    Tang, H.
    Wang, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1899 - S1899
  • [45] ALK-rearranged lung adenocarcinoma resistant to alectinib with cauliflower gingival metastasis responds to brigatinib
    Song, Lianxi
    Zeng, Liang
    Zhang, Yongchang
    [J]. THORACIC CANCER, 2022, 13 (07) : 1095 - 1097
  • [46] Near complete response to ceritinib in a pediatric patient with metastatic ALK-rearranged lung adenocarcinoma
    Liu, Zuhui
    Liu, Maolin
    Hou, Xue
    [J]. LUNG CANCER, 2023, 176 : 140 - 143
  • [47] Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas
    Sholl, Lynette M.
    Weremowicz, Stanislawa
    Gray, Stacy W.
    Wong, Kwok-Kin
    Chirieac, Lucian R.
    Lindeman, Neal I.
    Hornick, Jason L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 322 - 328
  • [48] Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review
    Sasano, Hajime
    Sekine, Akimasa
    Hirata, Toru
    Iwamoto, Keisuke
    Itou, Yuhei
    Itani, Hidetoshi
    Kondou, Shigeto
    Tokui, Toshiya
    Tanigawa, Motoaki
    [J]. INTERNAL MEDICINE, 2018, 57 (22) : 3271 - 3275
  • [49] A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor Heterogeneity
    Stockhammer, P.
    Ho, C. S. L.
    Bankfalvi, A.
    Ploenes, T.
    Hegedus, L.
    Schuler, M.
    Aigner, C.
    Schramm, A.
    Hegedus, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S571 - S572
  • [50] Cytological features of ALK rearranged lung adenocarcinoma
    Miyata, K.
    Morita, S.
    Kondo, F.
    Soejima, Y.
    Tanaka, F.
    Mieno, M.
    Sawahe, M.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S93 - S93
12345